PATENT CLAIM ANALYSIS

Application Number: 15866081
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["564", "188000"]

Abstract:
Motuporamine agents having antimicrobial activity and uses thereof.

Claim (Index 4):
The method of  claim 13 , wherein the antibiotic comprises Ampicillin, Vancomycin, Gentamicin, Tetracycline, Chloramphenicol, Rifampin, Norfloxacin, Rifaximin, Tigecycline, Furazolidone, Triclosan, Cefoperazone, Silver sulfadiazine, Dapsone, Gemifloxacin, Sulfadimidine, Enoxacin, Sulfisoxazole, Ceftolozane, Prontosil, Sulfapyridine, Sulfamerazine, Grepafloxacin, Sulfamethoxypyridazine, Sulfalene, Acetic acid/hydrocortisone, Sulfaphenazole, Sulfametoxydiazine, Sulfamoxole, Sulfabenzamide, Sulfametrole, Viridicatumtoxin B, Sulfametomidine, Sulfaperin, or Sulfathiourea.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 564.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12116164', '13984991', '11150428', '12613329', '11150522']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7198099825646815
- 35 USC 102 Novelty (BERT): 0.51766606131712
- Combined Prediction Score: 0.6995955904399255
- Mean Citation Score: 223.38617
- Max Citation Score: 225.85655
- Similarity Product: 161.79424203485252

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test